Yahoo Web Search

Search results

    • AbbVie makes oncology progress with two drug trials

      Crain s Chicago Business· 18 hours ago

      Multiple myeloma, the second-most common blood cancer, is characterized by abnormal proliferation of plasma cells, which can cause end-organ damage, AbbVie said in a statement. The start of ...

    • Binge-Eating Disorder May Linger for Years

      Binge-Eating Disorder May Linger for Years

      Medscape· 3 days ago

      Binge-eating disorder (BED) often improves with time, but full remission can take many years and relapse is common, new research suggested. "The big...

    • New blood test 'can predict' breast cancer return

      BBC via AOL· 5 days ago

      An "ultra-sensitive" new blood test can predict if breast cancer will return years before the disease shows up on scans, researchers say. It picks up traces of a tumour's DNA before a full & ...